More interestingly, Abou-Elkacem et al. found that regorafenib significantly reduced macrophage TIE2 expression, but the effect was apparent only after 14 days of cancer cell implantation in an orthotopic murine model of colorectal cancer. Here, TEK is linked to colorectal cancer.